SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640455-19-000021
Filing Date
2019-03-06
Accepted
2019-03-06 11:09:16
Documents
90
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jnce1231201810-k.htm 10-K 1682822
2 EXHIBIT 21.1 jnce12312018exhibit211.htm EX-21.1 13905
3 EXHIBIT 23.1 jnce12312018exhibit231.htm EX-23.1 4708
4 EXHIBIT 31.1 jnce12312018exhibit311.htm EX-31.1 10660
5 EXHIBIT 31.2 jnce12312018exhibit312.htm EX-31.2 10668
6 EXHIBIT 32.1 jnce12312018exhibit321.htm EX-32.1 11714
13 pipeline2019.jpg GRAPHIC 85310
  Complete submission text file 0001640455-19-000021.txt   7995985

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT jnce-20181231.xml EX-101.INS 1518258
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20181231.xsd EX-101.SCH 56616
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20181231_cal.xml EX-101.CAL 94105
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20181231_def.xml EX-101.DEF 302693
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20181231_lab.xml EX-101.LAB 782334
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20181231_pre.xml EX-101.PRE 484009
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37998 | Film No.: 19661634
SIC: 2836 Biological Products, (No Diagnostic Substances)